Evidence map›Paper›PMID 35299902›Full record

ArticleJournal of parasitic diseases : official organ of the Indian Society for Parasitology2022

Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.

Amal Farahat Allam, Nancy Abd-Elkader Hagras, Hoda Fahmy Farag, Mervat Mostafa Osman, Thanaa Ibrahim Shalaby, Amani Hussein Kazem, Amel Youssef Shehab, Nermine Mogahed Fawzy Hussein Mogahed

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of parasitic diseases : official organ of the Indian Society for Parasitology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Amal Farahat AllamDepartment of Parasitology, Medical Research Institute, Alexandria University, 165 El Horreya Avenue, El Hadara, Alexandria, Egypt.ORCID 0000-0002-4965-9469
Nancy Abd-Elkader HagrasDepartment of Medical Laboratory, Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, Egypt.
Hoda Fahmy FaragDepartment of Parasitology, Medical Research Institute, Alexandria University, 165 El Horreya Avenue, El Hadara, Alexandria, Egypt.
Mervat Mostafa OsmanDepartment of Parasitology, Medical Research Institute, Alexandria University, 165 El Horreya Avenue, El Hadara, Alexandria, Egypt.
Thanaa Ibrahim ShalabyDepartment of Medical Biophysics, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Amani Hussein KazemDepartment of Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Amel Youssef ShehabDepartment of Parasitology, Medical Research Institute, Alexandria University, 165 El Horreya Avenue, El Hadara, Alexandria, Egypt.
Nermine Mogahed Fawzy Hussein MogahedDepartment of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Alexandria University · EGPharos University in Alexandria · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study investigated the anti-Toxoplasma effect of chitosan nanoparticles [CS NPs], spiramycin, spiramycin co-administered with metronidazole and spiramycin-CS NPs formulation on the parasite burden and histopathological changes in the liver, spleen and brain in experimentally infected mice

Indexed as

Chitosan nanoparticlesSpiramycinSpiramycin-chitosan nanoparticles formulationSpiramycin-metronidazoleToxoplasma gondii

Identifiers

PMID35299902
PMCPMC8901813
OpenAlexW3191991362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.